Q1 2025 UFP Technologies Inc Earnings Call Transcript
Key Points
- UFP Technologies Inc (UFPT) reported a strong first quarter with revenue growth of 41%, operating income increase of 45%, and EPS growth of 35% to $2.21.
- The medical business segment grew by 50%, driven by strong demand in the safe patient handling space, making it the second largest segment behind robotic surgery.
- Recent acquisitions have performed well, contributing significantly to growth, with organic growth at 2.3% and Medtech growth at 5.4%.
- UFP Technologies Inc (UFPT) signed a key customer agreement in the safe patient handling space, providing exclusive manufacturing rights through mid-2030, supporting a large portion of the revenue acquired with the AJR business.
- The company is expanding its Dominican Republic operations, doubling the size of its facility in Santiago, which is a key competitive differentiator and an important component of its growth strategy.
- The robotic surgery segment experienced a 6% decline in Q1 and is expected to have only modest growth in 2025 due to the completion of an inventory build by the largest customer in 2024.
- Gross margin slightly decreased to 28.5% from 28.6% in the first quarter of 2024, partly due to inefficiencies in the newly acquired AJR operations related to onboarding new direct labor associates.
- Advanced Components segment saw a 16.3% decline as resources were focused on faster-growing medtech opportunities.
- There is uncertainty regarding the impact of tariffs on demand from customers and potential inflationary effects on incoming raw materials.
- The company anticipates continued inefficiencies at AJR through the second quarter as it continues to onboard new associates.
Good day, and welcome to the UFP Technologies first-quarter of 2025 earnings call. (Operator Instructions) Also, please be aware that today's call is being recorded.
I would now like to turn the call over to the Chief Financial Officer, Ron Lataille. Please go ahead, sir.
Thank you, operator. Good morning and thank you for joining us on our first quarter 2025 earnings conference call. With me on today's call is our CEO and Chairman, Jeff Bailly.
Today, we will be making forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995, the accuracy of which is subject to risks and uncertainties. Wherever possible, we will try to identify those forward-looking statements by using words such as believe, expect, anticipate, pursue, forecast and similar expressions.
Our forward-looking statements are based on our estimates and assumptions as of today and should not be relied upon as representing our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
